Skip to main content
Top
Published in: Infection 4/2010

01-08-2010 | Clinical and Epidemiological Study

Comparison of hospital-wide and unit-specific cumulative antibiograms in hospital- and community-acquired infection

Authors: F. Lamoth, A. Wenger, G. Prod’hom, Y. Vallet, C. Plüss-Suard, J. Bille, G. Zanetti

Published in: Infection | Issue 4/2010

Login to get access

Abstract

Background

Empirical antibacterial therapy in hospitals is usually guided by local epidemiologic features reflected by institutional cumulative antibiograms. We investigated additional information inferred by aggregating cumulative antibiograms by type of unit or according to the place of acquisition (i.e. community vs. hospital) of the bacteria.

Materials and methods

Antimicrobial susceptibility rates of selected pathogens were collected over a 4-year period in an university-affiliated hospital. Hospital-wide antibiograms were compared with those selected by type of unit and sampling time (<48 or >48 h after hospital admission).

Results

Strains isolated >48 h after admission were less susceptible than those presumably arising from the community (<48 h). The comparison of units revealed significant differences among strains isolated >48 h after admission. When compared to hospital-wide antibiograms, susceptibility rates were lower in the ICU and surgical units for Escherichia coli to amoxicillin-clavulanate, enterococci to penicillin, and Pseudomonas aeruginosa to anti-pseudomonal beta-lactams, and in medical units for Staphylococcus aureus to oxacillin. In contrast, few differences were observed among strains isolated within 48 h of admission.

Conclusions

Hospital-wide antibiograms reflect the susceptibility pattern for a specific unit with respect to community-acquired, but not to hospital-acquired strains. Antibiograms adjusted to these parameters may be useful in guiding the choice of empirical antibacterial therapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003;115:529–35.CrossRefPubMed Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003;115:529–35.CrossRefPubMed
2.
go back to reference Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462–74.CrossRefPubMed Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462–74.CrossRefPubMed
3.
go back to reference Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96.CrossRefPubMed Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96.CrossRefPubMed
4.
go back to reference Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis. 1999;29:245–52.CrossRefPubMed Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis. 1999;29:245–52.CrossRefPubMed
5.
go back to reference Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA. 1996;275:234–40.CrossRefPubMed Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA. 1996;275:234–40.CrossRefPubMed
6.
go back to reference Fridkin SK, Edwards JR, Tenover FC, Gaynes RP, McGowan JE Jr. Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections. Clin Infect Dis. 2001;33:324–30.CrossRefPubMed Fridkin SK, Edwards JR, Tenover FC, Gaynes RP, McGowan JE Jr. Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections. Clin Infect Dis. 2001;33:324–30.CrossRefPubMed
7.
go back to reference Binkley S, Fishman NO, LaRosa LA, Marr AM, Nachamkin I, Wordell D, et al. Comparison of unit-specific and hospital-wide antibiograms: potential implications for selection of empirical antimicrobial therapy. Infect Control Hosp Epidemiol. 2006;27:682–7.CrossRefPubMed Binkley S, Fishman NO, LaRosa LA, Marr AM, Nachamkin I, Wordell D, et al. Comparison of unit-specific and hospital-wide antibiograms: potential implications for selection of empirical antimicrobial therapy. Infect Control Hosp Epidemiol. 2006;27:682–7.CrossRefPubMed
8.
go back to reference Bryce EA, Smith JA. Focused microbiological surveillance and gram-negative beta-lactamase–mediated resistance in an intensive care unit. Infect Control Hosp Epidemiol. 1995;16:331–4.CrossRefPubMed Bryce EA, Smith JA. Focused microbiological surveillance and gram-negative beta-lactamase–mediated resistance in an intensive care unit. Infect Control Hosp Epidemiol. 1995;16:331–4.CrossRefPubMed
9.
go back to reference Kaufman D, Haas CE, Edinger R, Hollick G. Antibiotic susceptibility in the surgical intensive care unit compared with the hospital-wide antibiogram. Arch Surg. 1998;133:1041–5.CrossRefPubMed Kaufman D, Haas CE, Edinger R, Hollick G. Antibiotic susceptibility in the surgical intensive care unit compared with the hospital-wide antibiogram. Arch Surg. 1998;133:1041–5.CrossRefPubMed
10.
go back to reference Namias N, Samiian L, Nino D, Shirazi E, O’Neill K, Kett DH, et al. Incidence and susceptibility of pathogenic bacteria vary between intensive care units within a single hospital: implications for empiric antibiotic strategies. J Trauma. 2000;49:638–45.CrossRefPubMed Namias N, Samiian L, Nino D, Shirazi E, O’Neill K, Kett DH, et al. Incidence and susceptibility of pathogenic bacteria vary between intensive care units within a single hospital: implications for empiric antibiotic strategies. J Trauma. 2000;49:638–45.CrossRefPubMed
11.
go back to reference Pierson CL, Friedman BA. Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units. Diagn Microbiol Infect Dis. 1992;15:19S–30S.CrossRefPubMed Pierson CL, Friedman BA. Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units. Diagn Microbiol Infect Dis. 1992;15:19S–30S.CrossRefPubMed
12.
go back to reference Stratton CW, Ratner H, Johnston PE, Schaffner W. Focused microbiologic surveillance by specific hospital unit as a sensitive means of defining antimicrobial resistance problems. Diagn Microbiol Infect Dis. 1992;15:11S–8S.CrossRefPubMed Stratton CW, Ratner H, Johnston PE, Schaffner W. Focused microbiologic surveillance by specific hospital unit as a sensitive means of defining antimicrobial resistance problems. Diagn Microbiol Infect Dis. 1992;15:11S–8S.CrossRefPubMed
13.
go back to reference Archibald L, Phillips L, Monnet D, McGowan JE Jr, Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis. 1992;24:211–5. Archibald L, Phillips L, Monnet D, McGowan JE Jr, Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis. 1992;24:211–5.
14.
go back to reference Harbarth S, Rohner P, Safran E, Garbino J, Auckenthaler R, Pittet D. Resistance to amikacin and gentamicin among Gram-negative bloodstream isolates in a university hospital between 1989 and 1994. Clin Microbiol Infect. 1998;4:199–204.CrossRefPubMed Harbarth S, Rohner P, Safran E, Garbino J, Auckenthaler R, Pittet D. Resistance to amikacin and gentamicin among Gram-negative bloodstream isolates in a university hospital between 1989 and 1994. Clin Microbiol Infect. 1998;4:199–204.CrossRefPubMed
15.
go back to reference Jorgensen JH. Antibacterial agents and susceptibility test methods. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds) Clinical microbiology, vol. 1. 8th edn. Washington: ASM Press; 2003. p. 1037–213. Jorgensen JH. Antibacterial agents and susceptibility test methods. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds) Clinical microbiology, vol. 1. 8th edn. Washington: ASM Press; 2003. p. 1037–213.
16.
go back to reference Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 17th Informational supplement. CLSI, 2007 document M100-S17. Clinical and Laboratory Standards Institute, Wayne. 2007. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 17th Informational supplement. CLSI, 2007 document M100-S17. Clinical and Laboratory Standards Institute, Wayne. 2007.
17.
go back to reference Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–32.CrossRefPubMed Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–32.CrossRefPubMed
18.
go back to reference Stratton CW, Ratner H, Johnston PE, Schaffner W. Focused microbiologic surveillance by specific hospital unit: practical application and clinical utility. Clin Ther. 1993;15:12–20.PubMed Stratton CW, Ratner H, Johnston PE, Schaffner W. Focused microbiologic surveillance by specific hospital unit: practical application and clinical utility. Clin Ther. 1993;15:12–20.PubMed
19.
go back to reference Carmeli Y, Troillet N, Eliopoulos GM, Samore MH. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother. 1999;43:1379–82.PubMed Carmeli Y, Troillet N, Eliopoulos GM, Samore MH. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother. 1999;43:1379–82.PubMed
20.
go back to reference El Amari EB, Chamot E, Auckenthaler R, Pechere JC, Van Delden C. Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis. 2001;33:1859–64.CrossRefPubMed El Amari EB, Chamot E, Auckenthaler R, Pechere JC, Van Delden C. Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis. 2001;33:1859–64.CrossRefPubMed
21.
go back to reference Meyer E, Schwab F, Gastmeier P, Rueden H, Daschner FD. Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): a summary of the data from 2001 through 2004. Infection. 2006;34:303–9.CrossRefPubMed Meyer E, Schwab F, Gastmeier P, Rueden H, Daschner FD. Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): a summary of the data from 2001 through 2004. Infection. 2006;34:303–9.CrossRefPubMed
Metadata
Title
Comparison of hospital-wide and unit-specific cumulative antibiograms in hospital- and community-acquired infection
Authors
F. Lamoth
A. Wenger
G. Prod’hom
Y. Vallet
C. Plüss-Suard
J. Bille
G. Zanetti
Publication date
01-08-2010
Publisher
Urban and Vogel
Published in
Infection / Issue 4/2010
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-010-0033-0

Other articles of this Issue 4/2010

Infection 4/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.